66. 在肝癌的 systemic therapy 中,下列何者是屬於 immune checkpoint inhibitor 類治療藥物?
(1) Cabozantinib
(2) Durvalumab
(3) Bevacizumab
(4) Tremelimumab
(5) Atezolizumab
(A) (1)+(2)+(3)
(B) (2)+(3)+(4)
(C) (1)+(3)+(5)
(D) (2)+(4)+(5)
(E) (3)+(4)+(5)
(1) Cabozantinib
(2) Durvalumab
(3) Bevacizumab
(4) Tremelimumab
(5) Atezolizumab
(A) (1)+(2)+(3)
(B) (2)+(3)+(4)
(C) (1)+(3)+(5)
(D) (2)+(4)+(5)
(E) (3)+(4)+(5)
答案:登入後查看
統計: A(0), B(0), C(0), D(5), E(0) #3585241
統計: A(0), B(0), C(0), D(5), E(0) #3585241